UAB "Biomedicinos technika" Finance - revenue, profit
EBITDA margin (%)
Register and
explore Okredo dataEBIT margin (%)
Register and
explore Okredo data| Indicator |
|---|
| Turnover (€) |
| Sales per employee (€) |
| Profit before tax (€) |
| Net Profit (€) |
| Profit per employee (€) |
| Total profitability (%) |
| Net profitability (%) |
| Equity (€) |
| Amounts Payable And Liabilities (€) |
| Non-current Assets (€) |
| CurrentAssets (€) |
| Working capital requirement |
| Debt-to-equity ratio |
| EBITDA margin (%) |
| EBITDA (€) |
| EBIT margin (%) |
| EBIT (€) |
| 2022 |
|---|
| 734,796 |
| 122,466 |
| 179,951 |
| 152,958 |
| 25,493 |
| 44.29 |
| 20.82 |
| 184,675 |
| 367,691 |
| 7,112 |
| 545,254 |
| 0.45 |
| 1.99 |
| - |
| - |
| 25.00 |
| 183,716 |
| 2023 |
|---|
| 755,584 |
| 125,931 |
| 125,720 |
| 106,675 |
| 17,779 |
| 42.09 |
| 14.12 |
| 238,392 |
| 380,251 |
| 3,843 |
| 614,800 |
| 0.59 |
| 1.60 |
| - |
| - |
| 19.04 |
| 143,837 |
| 2024 |
|---|
| 674,850 |
| 106,949 |
| 122,200 |
| 103,731 |
| 16,439 |
| 49.25 |
| 15.37 |
| 305,448 |
| 316,100 |
| 5,147 |
| 616,401 |
| 0.70 |
| 1.03 |
| - |
| - |
| 19.90 |
| 134,277 |
| 2024 |
|---|
| 674,850 |
| 106,949 |
| 122,200 |
| 103,731 |
| 16,439 |
| 49.25 |
| 15.37 |
| 305,448 |
| 316,100 |
| 5,147 |
| 616,401 |
| 0.70 |
| 1.03 |
| - |
| - |
| 19.90 |
| 134,277 |
Turnover (€)
2024
Turnover (€)
674,850 €-11 % *
Sales per employee (€)
106,949 €-15 % *
Profit before tax (€)
122,200 €-3 % *
Net Profit (€)
103,731 €-3 % *
Profit per employee (€)
16,439 €-8 % *
Total profitability (%)
49.25 %17.01 % *
Net profitability (%)
15.37 %8.85 % *
Equity (€)
305,448 €28 % *
Amounts Payable And Liabilities (€)
316,100 €-17 % *
Non-current Assets (€)
5,147 €34 % *
CurrentAssets (€)
616,401 €0 % *
Working capital requirement
0.70 18.64 % *
Debt-to-equity ratio
1.03 -35.63 % *
EBITDA margin (%)
-EBITDA (€)
-EBIT margin (%)
19.90 %4.52 % *
EBIT (€)
134,277 €-7 % *
